Prelude therapeutics to participate in barclays global healthcare conference

Wilmington, del., feb. 29, 2024 (globe newswire) -- prelude therapeutics incorporated (prelude) (nasdaq: prld), a clinical-stage precision oncology company, announced today that the company will participate in the barclays global healthcare conference in miami, march 12-14, 2024.

PRLD Ratings Summary

PRLD Quant Ranking